We selected KNS-42 along with two additional cell lines from our pediatric brain tumor cohort with high CLK1 exon 4 PSI (7316–1763 and 7316–1769) to experimentally validate the exon 4 splice event identified from short-read RNA-Seq. This evidence concerns the gene CLK1 and brain neoplasm.